Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2 | Others | Unspecified | Potency | 31622.8 | nM | 21924799 | ||
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 44668.4 | nM | 16499313 | |
NPT831 | Individual Protein | Serine/threonine-protein kinase PLK1 | Homo sapiens | Potency | 26679.5 | nM | 24180210 | |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 44668.4 | nM | 19193025 | |
NPT2 | Others | Unspecified | IC50 | > | 99000 | nM | 18052030 | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 44668.4 | nM | 10924160 | |
NPT864 | Individual Protein | Lethal(3)malignant brain tumor-like protein 1 | Homo sapiens | Potency | = | 31622.8 | nM | 13678412 |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 44668.4 | nM | 17315963 | |
NPT100 | Individual Protein | Glutaminase kidney isoform, mitochondrial | Homo sapiens | Potency | 17782.8 | nM | DrugMatrix in vitro pharmacology data | |
NPT2752 | Individual Protein | DNA (cytosine-5)-methyltransferase 1 | Homo sapiens | IC50 | = | 7560 | nM | 19128055 |
NPT821 | Individual Protein | Werner syndrome ATP-dependent helicase | Homo sapiens | Potency | 35481.3 | nM | 10.6019/CHEMBL1201861 | |
NPT2 | Others | Unspecified | Inhibition | = | 13 | % | 16562840 | |
NPT2953 | Individual Protein | Acyl-CoA synthase | Mycobacterium tuberculosis | AC50 | 87230 | nM | 15646539 | |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | 8912.5 | nM | 16643049 | |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 25118.9 | nM | 26005918 |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 50118.7 | nM | 22834923 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC284810 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9467 | High Similarity | NPC215060 |
0.9467 | High Similarity | NPC476352 |
0.9463 | High Similarity | NPC114740 |
0.9459 | High Similarity | NPC96294 |
0.9329 | High Similarity | NPC93924 |
0.9272 | High Similarity | NPC213197 |
0.9262 | High Similarity | NPC15577 |
0.9262 | High Similarity | NPC52740 |
0.915 | High Similarity | NPC150442 |
0.9139 | High Similarity | NPC212670 |
0.9139 | High Similarity | NPC206264 |
0.9139 | High Similarity | NPC313334 |
0.9085 | High Similarity | NPC53587 |
0.9085 | High Similarity | NPC169404 |
0.9085 | High Similarity | NPC176186 |
0.9079 | High Similarity | NPC294522 |
0.9079 | High Similarity | NPC120426 |
0.9079 | High Similarity | NPC21184 |
0.9079 | High Similarity | NPC205727 |
0.9073 | High Similarity | NPC478237 |
0.9013 | High Similarity | NPC30688 |
0.9013 | High Similarity | NPC176903 |
0.9007 | High Similarity | NPC231149 |
0.9007 | High Similarity | NPC41844 |
0.8961 | High Similarity | NPC120774 |
0.8961 | High Similarity | NPC264875 |
0.8961 | High Similarity | NPC163598 |
0.8947 | High Similarity | NPC187398 |
0.8947 | High Similarity | NPC476348 |
0.894 | High Similarity | NPC199928 |
0.8889 | High Similarity | NPC106138 |
0.8882 | High Similarity | NPC476347 |
0.8874 | High Similarity | NPC476450 |
0.8859 | High Similarity | NPC300611 |
0.8839 | High Similarity | NPC470264 |
0.8808 | High Similarity | NPC232228 |
0.8808 | High Similarity | NPC292443 |
0.8808 | High Similarity | NPC185127 |
0.88 | High Similarity | NPC145319 |
0.875 | High Similarity | NPC226722 |
0.8742 | High Similarity | NPC138212 |
0.8742 | High Similarity | NPC252169 |
0.8742 | High Similarity | NPC478239 |
0.8727 | High Similarity | NPC163165 |
0.8725 | High Similarity | NPC43500 |
0.8725 | High Similarity | NPC164148 |
0.8716 | High Similarity | NPC103409 |
0.8693 | High Similarity | NPC205361 |
0.8675 | High Similarity | NPC475084 |
0.8675 | High Similarity | NPC157816 |
0.8675 | High Similarity | NPC264735 |
0.8667 | High Similarity | NPC210478 |
0.8639 | High Similarity | NPC36138 |
0.8636 | High Similarity | NPC471764 |
0.8636 | High Similarity | NPC87950 |
0.8636 | High Similarity | NPC227902 |
0.8627 | High Similarity | NPC85624 |
0.8623 | High Similarity | NPC198324 |
0.8623 | High Similarity | NPC472385 |
0.8609 | High Similarity | NPC476442 |
0.8609 | High Similarity | NPC215512 |
0.8609 | High Similarity | NPC186406 |
0.8608 | High Similarity | NPC8712 |
0.8599 | High Similarity | NPC302610 |
0.8591 | High Similarity | NPC104167 |
0.8591 | High Similarity | NPC37468 |
0.8588 | High Similarity | NPC470416 |
0.8581 | High Similarity | NPC309953 |
0.8581 | High Similarity | NPC48366 |
0.8581 | High Similarity | NPC175976 |
0.8571 | High Similarity | NPC139571 |
0.8571 | High Similarity | NPC476865 |
0.8571 | High Similarity | NPC477895 |
0.8571 | High Similarity | NPC217520 |
0.8571 | High Similarity | NPC125755 |
0.8563 | High Similarity | NPC43211 |
0.8563 | High Similarity | NPC115760 |
0.8563 | High Similarity | NPC237435 |
0.8563 | High Similarity | NPC477848 |
0.8563 | High Similarity | NPC169645 |
0.8563 | High Similarity | NPC210094 |
0.8563 | High Similarity | NPC49344 |
0.8563 | High Similarity | NPC135277 |
0.8563 | High Similarity | NPC101191 |
0.8563 | High Similarity | NPC84482 |
0.8554 | High Similarity | NPC153755 |
0.8553 | High Similarity | NPC140502 |
0.8533 | High Similarity | NPC20796 |
0.8533 | High Similarity | NPC124149 |
0.8529 | High Similarity | NPC470449 |
0.8529 | High Similarity | NPC470446 |
0.8529 | High Similarity | NPC470445 |
0.8529 | High Similarity | NPC470447 |
0.8526 | High Similarity | NPC283839 |
0.8526 | High Similarity | NPC90896 |
0.8519 | High Similarity | NPC311803 |
0.8519 | High Similarity | NPC472859 |
0.8519 | High Similarity | NPC25389 |
0.8516 | High Similarity | NPC15538 |
0.8516 | High Similarity | NPC232992 |
0.8516 | High Similarity | NPC296377 |
0.8516 | High Similarity | NPC473480 |
0.8514 | High Similarity | NPC233018 |
0.8514 | High Similarity | NPC241341 |
0.8514 | High Similarity | NPC36437 |
0.8512 | High Similarity | NPC211532 |
0.8512 | High Similarity | NPC472380 |
0.8512 | High Similarity | NPC472384 |
0.8512 | High Similarity | NPC233994 |
0.8512 | High Similarity | NPC472382 |
0.8509 | High Similarity | NPC173726 |
0.8509 | High Similarity | NPC241600 |
0.8506 | High Similarity | NPC476864 |
0.8506 | High Similarity | NPC138915 |
0.8506 | High Similarity | NPC252292 |
0.8506 | High Similarity | NPC476866 |
0.8506 | High Similarity | NPC161700 |
0.8506 | High Similarity | NPC100998 |
0.8506 | High Similarity | NPC475096 |
0.8506 | High Similarity | NPC476868 |
0.8506 | High Similarity | NPC476869 |
0.8506 | High Similarity | NPC34927 |
0.8506 | High Similarity | NPC476382 |
0.8506 | High Similarity | NPC34587 |
0.8506 | High Similarity | NPC277867 |
0.8503 | High Similarity | NPC101026 |
0.8503 | High Similarity | NPC42773 |
0.8503 | High Similarity | NPC21666 |
0.8503 | High Similarity | NPC45522 |
0.8503 | High Similarity | NPC169977 |
0.8503 | High Similarity | NPC24043 |
0.8503 | High Similarity | NPC4390 |
0.8497 | Intermediate Similarity | NPC7439 |
0.8497 | Intermediate Similarity | NPC110067 |
0.8497 | Intermediate Similarity | NPC91492 |
0.8497 | Intermediate Similarity | NPC256555 |
0.8497 | Intermediate Similarity | NPC34245 |
0.8494 | Intermediate Similarity | NPC206123 |
0.8494 | Intermediate Similarity | NPC116864 |
0.8494 | Intermediate Similarity | NPC244776 |
0.8485 | Intermediate Similarity | NPC135345 |
0.8481 | Intermediate Similarity | NPC289967 |
0.8481 | Intermediate Similarity | NPC472611 |
0.8481 | Intermediate Similarity | NPC472612 |
0.848 | Intermediate Similarity | NPC470455 |
0.848 | Intermediate Similarity | NPC470451 |
0.8477 | Intermediate Similarity | NPC13067 |
0.8477 | Intermediate Similarity | NPC100389 |
0.8477 | Intermediate Similarity | NPC212770 |
0.8477 | Intermediate Similarity | NPC98777 |
0.8471 | Intermediate Similarity | NPC476871 |
0.8471 | Intermediate Similarity | NPC238140 |
0.8467 | Intermediate Similarity | NPC286843 |
0.8467 | Intermediate Similarity | NPC166180 |
0.8462 | Intermediate Similarity | NPC173837 |
0.8462 | Intermediate Similarity | NPC169510 |
0.8462 | Intermediate Similarity | NPC35167 |
0.8457 | Intermediate Similarity | NPC166277 |
0.8457 | Intermediate Similarity | NPC119125 |
0.8456 | Intermediate Similarity | NPC474600 |
0.8452 | Intermediate Similarity | NPC81042 |
0.8452 | Intermediate Similarity | NPC99515 |
0.8452 | Intermediate Similarity | NPC268515 |
0.8452 | Intermediate Similarity | NPC223426 |
0.8452 | Intermediate Similarity | NPC214621 |
0.8452 | Intermediate Similarity | NPC34267 |
0.8452 | Intermediate Similarity | NPC40222 |
0.8452 | Intermediate Similarity | NPC190714 |
0.8446 | Intermediate Similarity | NPC137669 |
0.8446 | Intermediate Similarity | NPC162093 |
0.8443 | Intermediate Similarity | NPC117260 |
0.8443 | Intermediate Similarity | NPC254540 |
0.8443 | Intermediate Similarity | NPC211594 |
0.8443 | Intermediate Similarity | NPC190003 |
0.8443 | Intermediate Similarity | NPC172807 |
0.8443 | Intermediate Similarity | NPC475155 |
0.8443 | Intermediate Similarity | NPC476405 |
0.8443 | Intermediate Similarity | NPC175107 |
0.8442 | Intermediate Similarity | NPC168579 |
0.8442 | Intermediate Similarity | NPC76176 |
0.8442 | Intermediate Similarity | NPC469313 |
0.8442 | Intermediate Similarity | NPC297342 |
0.8442 | Intermediate Similarity | NPC138227 |
0.8442 | Intermediate Similarity | NPC476867 |
0.8434 | Intermediate Similarity | NPC225434 |
0.8434 | Intermediate Similarity | NPC203050 |
0.8434 | Intermediate Similarity | NPC223747 |
0.8434 | Intermediate Similarity | NPC120099 |
0.8434 | Intermediate Similarity | NPC219904 |
0.8431 | Intermediate Similarity | NPC469559 |
0.8431 | Intermediate Similarity | NPC189115 |
0.8431 | Intermediate Similarity | NPC473792 |
0.8431 | Intermediate Similarity | NPC473873 |
0.8428 | Intermediate Similarity | NPC246893 |
0.8428 | Intermediate Similarity | NPC78809 |
0.8421 | Intermediate Similarity | NPC202700 |
0.8415 | Intermediate Similarity | NPC121290 |
0.8412 | Intermediate Similarity | NPC110941 |
0.8412 | Intermediate Similarity | NPC473571 |
0.8412 | Intermediate Similarity | NPC470444 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC284810 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9139 | High Similarity | NPD1653 | Approved |
0.8563 | High Similarity | NPD4338 | Clinical (unspecified phase) |
0.8343 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8333 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8284 | Intermediate Similarity | NPD7251 | Discontinued |
0.8214 | Intermediate Similarity | NPD7054 | Approved |
0.8166 | Intermediate Similarity | NPD7472 | Approved |
0.8117 | Intermediate Similarity | NPD7266 | Discontinued |
0.8098 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8098 | Intermediate Similarity | NPD5402 | Approved |
0.8059 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7941 | Intermediate Similarity | NPD3818 | Discontinued |
0.7895 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7895 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7892 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.787 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7843 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7843 | Intermediate Similarity | NPD1613 | Approved |
0.7831 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7824 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7824 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7824 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7785 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7778 | Intermediate Similarity | NPD5403 | Approved |
0.7764 | Intermediate Similarity | NPD5401 | Approved |
0.7751 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7733 | Intermediate Similarity | NPD7228 | Approved |
0.7714 | Intermediate Similarity | NPD7549 | Discontinued |
0.7701 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7677 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7677 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7651 | Intermediate Similarity | NPD37 | Approved |
0.7647 | Intermediate Similarity | NPD3027 | Phase 3 |
0.763 | Intermediate Similarity | NPD3751 | Discontinued |
0.7619 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7619 | Intermediate Similarity | NPD4965 | Approved |
0.7619 | Intermediate Similarity | NPD4966 | Approved |
0.7605 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7605 | Intermediate Similarity | NPD2801 | Approved |
0.7602 | Intermediate Similarity | NPD3787 | Discontinued |
0.7584 | Intermediate Similarity | NPD1091 | Approved |
0.7582 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7578 | Intermediate Similarity | NPD6190 | Approved |
0.7574 | Intermediate Similarity | NPD7075 | Discontinued |
0.7562 | Intermediate Similarity | NPD6674 | Discontinued |
0.7557 | Intermediate Similarity | NPD6559 | Discontinued |
0.7557 | Intermediate Similarity | NPD7240 | Approved |
0.7545 | Intermediate Similarity | NPD6801 | Discontinued |
0.7545 | Intermediate Similarity | NPD1934 | Approved |
0.7529 | Intermediate Similarity | NPD6234 | Discontinued |
0.7516 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7515 | Intermediate Similarity | NPD3882 | Suspended |
0.75 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7485 | Intermediate Similarity | NPD6799 | Approved |
0.7473 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7458 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7455 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7436 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7396 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7396 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7389 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7384 | Intermediate Similarity | NPD5494 | Approved |
0.7351 | Intermediate Similarity | NPD422 | Phase 1 |
0.7321 | Intermediate Similarity | NPD4380 | Phase 2 |
0.729 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7289 | Intermediate Similarity | NPD1512 | Approved |
0.7289 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7278 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7273 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7261 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7261 | Intermediate Similarity | NPD6798 | Discontinued |
0.7244 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7233 | Intermediate Similarity | NPD4340 | Discontinued |
0.7233 | Intermediate Similarity | NPD1933 | Approved |
0.7225 | Intermediate Similarity | NPD919 | Approved |
0.7219 | Intermediate Similarity | NPD6599 | Discontinued |
0.7213 | Intermediate Similarity | NPD6842 | Approved |
0.7213 | Intermediate Similarity | NPD6841 | Approved |
0.7213 | Intermediate Similarity | NPD6843 | Phase 3 |
0.7208 | Intermediate Similarity | NPD3225 | Approved |
0.7193 | Intermediate Similarity | NPD7819 | Suspended |
0.7174 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7169 | Intermediate Similarity | NPD1511 | Approved |
0.7152 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD7097 | Phase 1 |
0.7143 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7143 | Intermediate Similarity | NPD8127 | Discontinued |
0.7143 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7125 | Intermediate Similarity | NPD6355 | Discontinued |
0.7117 | Intermediate Similarity | NPD5762 | Approved |
0.7117 | Intermediate Similarity | NPD5763 | Approved |
0.7091 | Intermediate Similarity | NPD3750 | Approved |
0.7089 | Intermediate Similarity | NPD7095 | Approved |
0.7088 | Intermediate Similarity | NPD8312 | Approved |
0.7088 | Intermediate Similarity | NPD8313 | Approved |
0.7086 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7083 | Intermediate Similarity | NPD7435 | Discontinued |
0.7078 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7076 | Intermediate Similarity | NPD7411 | Suspended |
0.707 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7059 | Intermediate Similarity | NPD3496 | Discontinued |
0.7045 | Intermediate Similarity | NPD1247 | Approved |
0.7032 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7024 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7019 | Intermediate Similarity | NPD447 | Suspended |
0.7013 | Intermediate Similarity | NPD3705 | Approved |
0.7013 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7006 | Intermediate Similarity | NPD6232 | Discontinued |
0.6994 | Remote Similarity | NPD3748 | Approved |
0.6988 | Remote Similarity | NPD4628 | Phase 3 |
0.6971 | Remote Similarity | NPD7975 | Clinical (unspecified phase) |
0.6963 | Remote Similarity | NPD7237 | Clinical (unspecified phase) |
0.6951 | Remote Similarity | NPD2796 | Approved |
0.6928 | Remote Similarity | NPD1357 | Approved |
0.6928 | Remote Similarity | NPD5698 | Clinical (unspecified phase) |
0.6927 | Remote Similarity | NPD6777 | Approved |
0.6927 | Remote Similarity | NPD6781 | Approved |
0.6927 | Remote Similarity | NPD6776 | Approved |
0.6927 | Remote Similarity | NPD6778 | Approved |
0.6927 | Remote Similarity | NPD6779 | Approved |
0.6927 | Remote Similarity | NPD6782 | Approved |
0.6927 | Remote Similarity | NPD6780 | Approved |
0.6914 | Remote Similarity | NPD230 | Phase 1 |
0.6908 | Remote Similarity | NPD5536 | Phase 2 |
0.6907 | Remote Similarity | NPD7680 | Approved |
0.6905 | Remote Similarity | NPD5058 | Phase 3 |
0.6894 | Remote Similarity | NPD4062 | Phase 3 |
0.6893 | Remote Similarity | NPD5677 | Discontinued |
0.6889 | Remote Similarity | NPD7473 | Discontinued |
0.6888 | Remote Similarity | NPD7583 | Approved |
0.6886 | Remote Similarity | NPD1878 | Clinical (unspecified phase) |
0.6886 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6882 | Remote Similarity | NPD7314 | Clinical (unspecified phase) |
0.6869 | Remote Similarity | NPD7875 | Clinical (unspecified phase) |
0.6869 | Remote Similarity | NPD7874 | Approved |
0.6867 | Remote Similarity | NPD1549 | Phase 2 |
0.6864 | Remote Similarity | NPD4357 | Discontinued |
0.686 | Remote Similarity | NPD8158 | Clinical (unspecified phase) |
0.6853 | Remote Similarity | NPD7585 | Approved |
0.6848 | Remote Similarity | NPD2935 | Discontinued |
0.6848 | Remote Similarity | NPD1551 | Phase 2 |
0.6835 | Remote Similarity | NPD2797 | Approved |
0.6834 | Remote Similarity | NPD7782 | Clinical (unspecified phase) |
0.6834 | Remote Similarity | NPD7783 | Phase 2 |
0.6833 | Remote Similarity | NPD7784 | Clinical (unspecified phase) |
0.6833 | Remote Similarity | NPD7852 | Clinical (unspecified phase) |
0.6824 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.6818 | Remote Similarity | NPD7768 | Phase 2 |
0.6813 | Remote Similarity | NPD1008 | Clinical (unspecified phase) |
0.6807 | Remote Similarity | NPD3540 | Phase 1 |
0.6807 | Remote Similarity | NPD1552 | Clinical (unspecified phase) |
0.6807 | Remote Similarity | NPD1550 | Clinical (unspecified phase) |
0.6802 | Remote Similarity | NPD3687 | Approved |
0.6802 | Remote Similarity | NPD3686 | Approved |
0.6788 | Remote Similarity | NPD7033 | Discontinued |
0.6782 | Remote Similarity | NPD7615 | Clinical (unspecified phase) |
0.6778 | Remote Similarity | NPD3926 | Phase 2 |
0.6771 | Remote Similarity | NPD6621 | Clinical (unspecified phase) |
0.677 | Remote Similarity | NPD4625 | Phase 3 |
0.6766 | Remote Similarity | NPD2424 | Discontinued |
0.6765 | Remote Similarity | NPD7212 | Phase 2 |
0.6765 | Remote Similarity | NPD7213 | Phase 3 |
0.6761 | Remote Similarity | NPD8443 | Clinical (unspecified phase) |
0.6761 | Remote Similarity | NPD5353 | Approved |
0.676 | Remote Similarity | NPD6959 | Discontinued |
0.6747 | Remote Similarity | NPD3539 | Phase 1 |
0.6735 | Remote Similarity | NPD7698 | Approved |
0.6735 | Remote Similarity | NPD7696 | Phase 3 |
0.6735 | Remote Similarity | NPD7697 | Approved |
0.6734 | Remote Similarity | NPD8151 | Discontinued |
0.6728 | Remote Similarity | NPD6410 | Clinical (unspecified phase) |
0.6728 | Remote Similarity | NPD3268 | Approved |
0.6727 | Remote Similarity | NPD4538 | Approved |
0.6727 | Remote Similarity | NPD4537 | Clinical (unspecified phase) |
0.6727 | Remote Similarity | NPD4536 | Approved |
0.6726 | Remote Similarity | NPD7421 | Clinical (unspecified phase) |
0.6725 | Remote Similarity | NPD7447 | Phase 1 |
0.6725 | Remote Similarity | NPD7446 | Clinical (unspecified phase) |
0.6725 | Remote Similarity | NPD7410 | Clinical (unspecified phase) |
0.6724 | Remote Similarity | NPD4678 | Approved |
0.6724 | Remote Similarity | NPD4675 | Approved |
0.6709 | Remote Similarity | NPD4749 | Approved |
0.6708 | Remote Similarity | NPD6832 | Phase 2 |
0.6707 | Remote Similarity | NPD1899 | Clinical (unspecified phase) |
0.6703 | Remote Similarity | NPD7038 | Approved |
0.6703 | Remote Similarity | NPD7039 | Approved |
0.6701 | Remote Similarity | NPD7870 | Phase 2 |
0.6701 | Remote Similarity | NPD7871 | Phase 2 |
0.6689 | Remote Similarity | NPD290 | Approved |
0.6689 | Remote Similarity | NPD1358 | Approved |
0.6689 | Remote Similarity | NPD5535 | Approved |
0.6687 | Remote Similarity | NPD1510 | Phase 2 |
0.6686 | Remote Similarity | NPD4110 | Phase 3 |
0.6686 | Remote Similarity | NPD5089 | Approved |
0.6686 | Remote Similarity | NPD5090 | Approved |
0.6686 | Remote Similarity | NPD7982 | Clinical (unspecified phase) |
0.6686 | Remote Similarity | NPD4109 | Clinical (unspecified phase) |
0.6684 | Remote Similarity | NPD8090 | Clinical (unspecified phase) |
0.6684 | Remote Similarity | NPD6823 | Phase 2 |
0.6683 | Remote Similarity | NPD7701 | Phase 2 |
PubChem CID   | 185819 |
ChEMBL   | CHEMBL1209491 |
ZINC   |
Molecular Weight:   | 514.11 |
ALogP:   | -2.2132 |
MLogP:   | 2.89 |
XLogP:   | 2.251 |
# Rotatable Bonds:   | 11 |
Polar Surface Area:   | 170.44 |
# H-Bond Aceptor:   | 7 |
# H-Bond Donor:   | 4 |
# Rings:   | 5 |
# Heavy Atoms:   | 37 |